title: Hereditary hyperferritinaemia cataract syndrome: does it exist in Switzerland?
abstract: Recent research in iron metabolism has revealed the existence of iron-responding elements in the 5'UTR of the mRNA of ferritin. Binding of these structures with iron-regulatory proteins regulates ferritin synthesis within the cell, according to the intracellular iron level. Several mutations of the iron-responding elements located at the 5'UTR of the L-ferritin subunit, which lead to the hereditary hyperferritinaemia cataract syndrome, an autosomal dominant hereditary disease, have been described. Patients with congenital bilateral nuclear cataract present high serum ferritin (360-2264 micrograms/l) in the absence of iron overload. The purpose of our study was to look for this syndrome in Switzerland and in particular in the Geneva population. About 3000 cases of cataract operated on during a 4-year period (1995-1998) in the University Clinic of Ophthalmology were screened. We found 135 patients operated on before the age of 51 years. However, only 19 had bilateral nuclear cataract. 15 patients agreed to undergo iron screening. In 2 of them, a slight elevation of ferritin (267 micrograms/l in a female, 416 micrograms/l in a male) was found in the absence of iron overload. In both cases there is a positive family history of cataract. DNA sequencing analysis in these patients showed a normal nucleotide sequence of the whole iron-responding elements region. One of them (male) was found to present the codon 63 mutation at HFE gene in the heterozygous state. Our local study indicates that hereditary hyperferritinaemia cataract syndrome is extremely rare in Switzerland. However, similar studies should be carried out in other regions of the country. Iron status evaluation and ferritin level monitoring should become routine examinations in all new cases presenting with bilateral nuclear cataract before the age of 50 years.
authors.affiliation: Division d'Hématologie, Hôpitaux Universitaires de Genève.
authors.forename: J
authors.initials: J
authors.lastname: Rosochova
authors.forename: A
authors.initials: A
authors.lastname: Kapetanios
authors.forename: C
authors.initials: C
authors.lastname: Pournaras
authors.forename: L
authors.initials: L
authors.lastname: Vadas
authors.forename: K
authors.initials: K
authors.lastname: Samii
authors.forename: P
authors.initials: P
authors.lastname: Beris
mesh_terms: D020121:5' Untranslated Regions; D001483:Base Sequence; D002386:Cataract / Q000453:epidemiology / Q000235:genetics*; D002387:Cataract Extraction; D005260:Female; D005293:Ferritins / Q000235:genetics*; D006801:Humans; D019189:Iron Metabolism Disorders / Q000453:epidemiology / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D013557:Switzerland / Q000453:epidemiology; D013577:Syndrome
chemical_list: D020121:5' Untranslated Regions; D005293:Ferritins